Jump Financial »

Black Diamond Therapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $109k 39k 2.81
2023-09-30 $32k 11k 2.87
2022-03-31 $33k 12k 2.77
2021-12-31 $209k 39k 5.32
2021-06-30 $256k 21k 12.18

More positions owned by Jump Financial

Invesco Qqq Tr Etf (QQQ)
Ishares Tr Etf (IWM)
Spdr S&p 500 Etf Tr Etf (SPY)
Vanguard Index Fds Etf (VOO)
Ishares Tr Etf (TLT)
Proshares Tr Etf (SQQQ)
Ishares Tr Etf (IVV)
Proshares Tr Etf (PSQ)
Microsoft Corp Common Stock (MSFT)
Spdr Ser Tr Etf (SPLG)
Nvidia Corporation Common Stock (NVDA)
Proshares Tr Etf (SSO)
Amazon Common Stock (AMZN)
Proshares Tr Etf (TQQQ)
Direxion Shs Etf Tr Etf (SPXL)

View all positions for Jump Financial

Top funds holding Black Diamond Therapeutics

Bellevue Group
T. Rowe Price Investment Management
NEA Management Company
RA Capital Management
Vanguard Group
Tang Capital Management
BlackRock
Artal Group
Laurion Capital Management
Kennedy Capital Management
Blue Owl Capital Holdings
Millennium Management
Boxer Capital
Susquehanna International
Geode Capital Management

View all funds holding Black Diamond Therapeutics